Zurich Cantonal Bank
ABUS icon

Zurich Cantonal Bank’s Arbutus Biopharma ABUS Stock Holding History

Zurich Cantonal Bank’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$564K Sell
125,233
-3,082
-2% -$13.5K ﹤0.01% 1775
2025
Q4 		$617K Buy
128,315
+27,977
+28% +$126K ﹤0.01% 1656
2025
Q3 		$456K Hold
100,338
– – ﹤0.01% 1791
2025
Q2 		$310K Buy
100,338
+16,175
+19% +$53.7K ﹤0.01% 1940
2025
Q1 		$294K Sell
84,163
-5,502
-6% -$18.3K ﹤0.01% 1900
2024
Q4 		$293K Buy
89,665
+52,162
+139% +$192K ﹤0.01% 1957
2024
Q3 		$144K Buy
37,503
+30,723
+453% +$118K ﹤0.01% 2277
2024
Q2 		$20.9K Sell
6,780
-101
-1% -$303 ﹤0.01% 2588
2024
Q1 		$17.8K Buy
+6,881
New +$17.8K ﹤0.01% 2635
2023
Q1 		– Sell
-6,178
Closed -$14.4K – 2856
2022
Q4 		$14.4K Sell
6,178
-1,185
-16% -$2.83K ﹤0.01% 2786
2022
Q3 		$14K Hold
7,363
– – ﹤0.01% 2841
2022
Q2 		$20K Sell
7,363
-745
-9% -$1.91K ﹤0.01% 2795
2022
Q1 		$24K Buy
+8,108
New +$24.8K ﹤0.01% 2647

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $329M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return